Inside Private Equity

2025 has barely begun, but it has already been an eventful year for large ophthalmology practice platforms and large medical supply distributors.

On Jan. 8, Massachusetts Gov. Maura Healey signed a law that will require all providers and provider organizations to give at least 60 days’ notice to the state before making certain changes to their operations or governance structure.

The relationship between health care providers and referral sources can present complex legal challenges.

In our prior blog post, we discussed the frequent need to separate, from a legal and financial perspective, the real property from the practice in order to consummate a practice transaction with a private equity buyer.

Selling a medical practice is a complex transaction that involves not only the assets of the practice itself but also implicates associated real estate.

On April 23, the Federal Trade Commission released a final rule banning most noncompetition clauses in employer-employee contracts as unfair methods of competition.

In our last post, we saw how rollover equity fits into the overall consideration paid to a selling physician owner of a physician practice.

As we discussed in our overview of the private equity, or PE, physician practice model, the buyer in an acquisition is often a PE-sponsored management services organization that purchases the nonclinical aspects of the practice’s business.

A pressing question on the mind of any practice owner when selling his or her practice is “how much money will I get?”

We’ve discussed non-compete restrictions and possible exceptions in our previous blog entries. In addition to non-competes, you can expect that the buyer of your practice will also expect you to agree to non-solicits and no-hires.